Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome.

Landstrom, Andrew P

Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome. [electronic resource] - Leukemia & lymphoma Nov 2007 - 2137-40 p. digital

Publication Type: Evaluation Study; Journal Article

1042-8194

10.1080/10428190701618284 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Benzamides
Chromosome Aberrations
Female
Follow-Up Studies
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis
Male
Middle Aged
Mosaicism--drug effects
Philadelphia Chromosome
Piperazines--therapeutic use
Prognosis
Pyrimidines--therapeutic use
Retrospective Studies
Survival Analysis
Treatment Outcome